title: Epidermolysis bullosa: novel and de novo premature termination codon and deletion mutations in the plectin gene predict late-onset muscular dystrophy.
abstract: Epidermolysis bullosa (EB) with late-onset muscular dystrophy (EB-MD) is a hemidesmosomal variant of EB due to mutations in the plectin gene (PLEC1). The age of onset of muscle involvement has been noted to vary from infancy to the fourth decade of life. Immunofluorescence of the patients' skin and muscle biopsies is usually negative for staining with antibodies recognizing plectin, a large cytoskeleton-associated anchorage protein. In this study we report novel plectin mutations in two families with EB. In both families, the proband was a newborn with neonatal blistering with no evidence for muscle weakness as yet. Peripheral blood DNA was isolated and examined by heteroduplex scanning strategy, protein truncation test (PTT), and/or direct sequencing of the plectin gene. One of the probands was compound heterozygote for nonsense mutations E2005X/K4460X, and the proband in the second family was compound heterozygote for deletion mutations 5083delG/2745-9del21, the latter mutation extending from -9 to +12 at the intron 22/exon 23 border. The mutations K4460X and 5083delG were not present in either one of the parents, thus being de novo events. In both cases, nonpaternity was excluded by microsatellite marker analysis. The stop codon mutations are predicted to result in the synthesis of a truncated protein lacking the carboxy-terminal globular domain of the protein and possibly causing nonsense-mediated decay of the corresponding mRNA. The 2745-9del21 deletion mutation abolishes the splice site at the intron 22/exon 23 junction, predicting abnormal splicing events. Because plectin deficiency is associated with muscular dystrophy, molecular diagnostics of the plectin gene provides prognostic value in evaluation of these patients who appear to be at risk to develop muscular dystrophy.
authors.affiliation: Departments of Dermatology and Cutaneous Biology, and Biochemistry and Molecular Pharmacology, and Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Jefferson Medical College, Philadelphia, PA 19107, USA.
authors.forename: F
authors.initials: F
authors.lastname: Rouan
authors.forename: L
authors.initials: L
authors.lastname: Pulkkinen
authors.forename: G
authors.initials: G
authors.lastname: Meneguzzi
authors.forename: S
authors.initials: S
authors.lastname: Laforgia
authors.forename: P
authors.initials: P
authors.lastname: Hyde
authors.forename: D U
authors.initials: DU
authors.lastname: Kim
authors.forename: G
authors.initials: G
authors.lastname: Richard
authors.forename: J
authors.initials: J
authors.lastname: Uitto
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D003062:Codon; D004820:Epidermolysis Bullosa / Q000235:genetics; D005192:Family Health; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007223:Infant; D007381:Intermediate Filament Proteins / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000235:genetics; D051190:Plectin; D017354:Point Mutation
chemical_list: D003062:Codon; D007381:Intermediate Filament Proteins; C495332:PLEC protein, human; D051190:Plectin